BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 27, 2003
View Archived Issues
NN-703 may be effective in adults with moderately severe GH deficiency
Read More
Antiviral and spermicidal agent WHI-05 in development
Read More
NXC-4720 generates positive data in validation studies
Read More
Improved vision in extension phase of Lucentis wet AMD study
Read More
Development of AS-1403 discontinued following phase I biodistribution results
Read More
Findings from DAC:GLP-1 studies reported
Read More
Vical and Merck & Co. amend license agreement
Read More
Medtronic to commercialize rhBMP-2 in Japan
Read More
Novel telomerase inhibitors covered by Cancer Research Technology patent
Read More
New mGluR5 antagonists in early development at Merck
Read More
Boehringer Igelheim describes new glucocorticoid receptor modulators and their use
Read More
Novel pyridazinone-based p38 kinase inhibitors prepared by Pharmacia researchers
Read More
Bayer scientists prepare and test new gamma-secretase inhibitors for AD therapy
Read More
DakoCytomation and Northwest Biotherapeutics to develop prostate cancer diagnostics
Read More
Zengen drug delivery technology used for oral strip products
Read More
Meditech and Elan extend joint venture
Read More
Phase II Campath trial in MS makes progress
Read More
TZE-5323: a potential therapeutic drug for the long-term treatment of endometriosis
Read More
Synthetic progestins with high tissue and receptor selectivity
Read More
PHA-927F reported to be a potent and selective inhibitor of tissue factor/factor VIIa
Read More
